<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction Schema extraction-schema-124 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extraction Schema Details for extraction-schema-124</h1>

        <div class="section">
            <h2>Extraction Schema (General Information)</h2>
            <div class="info-section">
                <p><strong>Schema ID:</strong> extraction-schema-124</p>
                <p><strong>Extraction Query:</strong> Extract any mentions of neuronal populations in the visual cortex that are selectively vulnerable or resistant to amyloid-β plaques and/or tau protein tangles in dementia, including the identity of the neuronal population, the type of pathology, evidence for vulnerability or resistance, proposed mechanisms or factors underlying this selectivity, disease context, and species or model studied.</p>
            </div>
        </div>

        <div class="section">
            <h2>Extraction Schema (Details)</h2>
            <table>
                <thead>
                    <tr>
                        <th style="width: 20%;">Field Name</th>
                        <th style="width: 15%;">Type</th>
                        <th style="width: 65%;">Description</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>neuronal_population</strong></td>
                        <td>str</td>
                        <td>The specific neuronal population in the visual cortex being discussed (e.g. 'layer 2/3 pyramidal neurons', 'parvalbumin interneurons', 'V1 neurons', 'calbindin-positive cells').</td>
                    </tr>
                    <tr>
                        <td><strong>vulnerability_status</strong></td>
                        <td>str</td>
                        <td>Whether the neuronal population is described as vulnerable, resistant, or intermediate to amyloid-β plaques and/or tau tangles (e.g. 'vulnerable', 'resistant', 'intermediate', 'no information').</td>
                    </tr>
                    <tr>
                        <td><strong>pathology_type</strong></td>
                        <td>str</td>
                        <td>The type of pathology affecting the neuronal population (e.g. 'amyloid-β', 'tau', 'both', 'other', 'no information').</td>
                    </tr>
                    <tr>
                        <td><strong>evidence_for_status</strong></td>
                        <td>str</td>
                        <td>A concise summary of the experimental or observational evidence supporting the vulnerability or resistance status (e.g. 'increased tau tangle density in layer 5 neurons', 'no amyloid-β detected in calretinin interneurons', 'cell loss observed', 'no pathology observed').</td>
                    </tr>
                    <tr>
                        <td><strong>proposed_mechanisms</strong></td>
                        <td>str</td>
                        <td>Any proposed mechanisms or factors underlying the selective vulnerability or resistance (e.g. 'differential expression of tau isoforms', 'synaptic connectivity patterns', 'metabolic differences', 'gene expression profiles', 'calcium buffering capacity').</td>
                    </tr>
                    <tr>
                        <td><strong>disease_context</strong></td>
                        <td>str</td>
                        <td>The disease context in which the findings were observed (e.g. 'Alzheimer's disease', 'frontotemporal dementia', 'mouse model of tauopathy').</td>
                    </tr>
                    <tr>
                        <td><strong>species_or_model</strong></td>
                        <td>str</td>
                        <td>The species or experimental model used in the study (e.g. 'human', 'mouse', 'rat', 'transgenic mouse model', 'postmortem human tissue').</td>
                    </tr>
                    <tr>
                        <td><strong>counterexamples_or_contradictions</strong></td>
                        <td>str</td>
                        <td>Any reported counterexamples, contradictory findings, or exceptions to the general pattern of vulnerability or resistance (e.g. 'some studies report resistance in layer 4 neurons, while others report vulnerability').</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <div class="section">
            <h2>Extraction Schema (Debug)</h2>
            <pre><code>{
    "id": "extraction-schema-124",
    "schema": [
        {
            "name": "neuronal_population",
            "type": "str",
            "description": "The specific neuronal population in the visual cortex being discussed (e.g. 'layer 2/3 pyramidal neurons', 'parvalbumin interneurons', 'V1 neurons', 'calbindin-positive cells')."
        },
        {
            "name": "vulnerability_status",
            "type": "str",
            "description": "Whether the neuronal population is described as vulnerable, resistant, or intermediate to amyloid-β plaques and/or tau tangles (e.g. 'vulnerable', 'resistant', 'intermediate', 'no information')."
        },
        {
            "name": "pathology_type",
            "type": "str",
            "description": "The type of pathology affecting the neuronal population (e.g. 'amyloid-β', 'tau', 'both', 'other', 'no information')."
        },
        {
            "name": "evidence_for_status",
            "type": "str",
            "description": "A concise summary of the experimental or observational evidence supporting the vulnerability or resistance status (e.g. 'increased tau tangle density in layer 5 neurons', 'no amyloid-β detected in calretinin interneurons', 'cell loss observed', 'no pathology observed')."
        },
        {
            "name": "proposed_mechanisms",
            "type": "str",
            "description": "Any proposed mechanisms or factors underlying the selective vulnerability or resistance (e.g. 'differential expression of tau isoforms', 'synaptic connectivity patterns', 'metabolic differences', 'gene expression profiles', 'calcium buffering capacity')."
        },
        {
            "name": "disease_context",
            "type": "str",
            "description": "The disease context in which the findings were observed (e.g. 'Alzheimer's disease', 'frontotemporal dementia', 'mouse model of tauopathy')."
        },
        {
            "name": "species_or_model",
            "type": "str",
            "description": "The species or experimental model used in the study (e.g. 'human', 'mouse', 'rat', 'transgenic mouse model', 'postmortem human tissue')."
        },
        {
            "name": "counterexamples_or_contradictions",
            "type": "str",
            "description": "Any reported counterexamples, contradictory findings, or exceptions to the general pattern of vulnerability or resistance (e.g. 'some studies report resistance in layer 4 neurons, while others report vulnerability')."
        }
    ],
    "extraction_query": "Extract any mentions of neuronal populations in the visual cortex that are selectively vulnerable or resistant to amyloid-β plaques and/or tau protein tangles in dementia, including the identity of the neuronal population, the type of pathology, evidence for vulnerability or resistance, proposed mechanisms or factors underlying this selectivity, disease context, and species or model studied.",
    "supporting_theory_ids": [],
    "model_str": "openai/gpt-4.1-2025-04-14"
}</code></pre>
        </div>
    </div>
</body>
</html>